"Dieufa" pathological diagnosis of adenotumor markers with primary antibodies (unsterilized) - Taiwan Registration f654265dc64f455fa4039f4e6cb79d13
Access comprehensive regulatory information for "Dieufa" pathological diagnosis of adenotumor markers with primary antibodies (unsterilized) in Taiwan's medical device market through Pure Global AI's free database. This Risk Class 1 medical device is registered under number f654265dc64f455fa4039f4e6cb79d13 and manufactured by DIANOVA GMBH. The authorized representative in Taiwan is BOND BIOTECH, INC..
This page provides complete technical specifications, regulatory compliance details. Pure Global AI offers free access to 89,000+ Taiwan medical device registrations, helping global MedTech companies navigate Taiwan FDA regulations, identify competitors, and discover partnership opportunities efficiently.
Device Details
Product Details
Limited to the first level identification range of immunopathological histochemical reagents and kits (B.1860) of the Measures for the Administration of Medical Devices.
B Hematology, pathology, and genetics
B.1860 Immunopathological histochemistry reagents and kits
import
Dates and Status
Oct 06, 2011
Oct 06, 2021
Sep 08, 2023
Cancellation Information
Logged out
ๆชๅฑๅปถ่้พๆ่